Investor mix
5 investors on record; lead investors include Tesi.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 40% |
| Private equity | 1 | 20% |
| Other / undisclosed | 2 | 40% |
Small molecule therapeutics for cancer and neurodegenerative diseases
5 investors on record; lead investors include Tesi.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 40% |
| Private equity | 1 | 20% |
| Other / undisclosed | 2 | 40% |